Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-19-008210
Filing Date
2019-02-07
Accepted
2019-02-07 18:14:27
Documents
2
Period of Report
2019-02-07

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 5023
2 POA DOCUMENT poa.txt EX-24.3_831181 3080
  Complete submission text file 0001209191-19-008210.txt   9485
Mailing Address C/O ADURO BIOTECH, INC. 740 HEINZ AVENUE BERKELEY CA 94710
Business Address
Sacks Natalie (Reporting) CIK: 0001683811 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38800 | Film No.: 19576672

Mailing Address 4000 SHORELINE CT #250 SOUTH SAN FRANCISCO CA 94080
Business Address 4000 SHORELINE CT #250 SOUTH SAN FRANCISCO CA 94080 650-443-7400
Harpoon Therapeutics, Inc. (Issuer) CIK: 0001708493 (see all company filings)

EIN.: 473458693 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)